Pulmatrix (PULM) Interest Expenses (2014 - 2026)
Pulmatrix (PULM) posted Interest Expenses of $50000.0 for Q1 2026, down 99.82% sequentially from $27.8 million in Q4 2025, and up 61.29% YoY from $31000.0 in Q1 2025.
Pulmatrix (PULM) Interest Expenses (2014 - 2026) Analysis & Trends
Pulmatrix has reported Interest Expenses for 13 years, with the latest figure at $50000.0 in Q1 2026.
- Quarterly Interest Expenses rose 61.29% year-over-year to $50000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50000.0 (up 61.29% YoY) and the FY2025 annual result came in at $27.8 million, up 3989.43% from the prior year.
- Interest Expenses fell to $50000.0 in Q1 2026 per PULM's latest filing, from $27.8 million in the prior quarter.
- Over five years, Interest Expenses peaked at $27.8 million in Q4 2025 and troughed at -$108000.0 in Q4 2023.
- A 5-year average of $3.0 million and a median of $315000.0 in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses sank 125.0% in 2023, then jumped 3202.32% in 2024.
- Over 5 years, Interest Expenses stood at $432000.0 in 2022, then tumbled by 125.0% to -$108000.0 in 2023, then soared by 122.22% to $24000.0 in 2024, then soared by 115937.5% to $27.8 million in 2025, then plunged by 99.82% to $50000.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $50000.0, $27.8 million, and $10000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50,000.00 |
| Jun 30, 2026 | 50,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | 27.85 Mn |
| Dec 31, 2025 | 27.85 Mn |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 322,000.00 |
| Mar 31, 2024 | 14.23 Mn |
| Mar 31, 2024 | 14.23 Mn |
| Dec 31, 2023 | -108,000.00 |
| Dec 31, 2023 | -108,000.00 |